ESG ratings & risk scores
ESG Solutions
At a glance
Verified June 2026 2023CommittedESG & Sustainability Profile
Genmab A/S is a leading pharmaceutical company based in Denmark, specializing in antibody therapeutics for cancer treatment. The company has a medium risk assessment with an ESG score of 20.4. Genmab's innovative proprietary antibody technologies, including DuoBody and HexaBody, have led to successful partnerships with major companies like Johnson & Johnson. Darzalex, their flagship product, is considered the standard of care for multiple myeloma. Genmab also offers Tepezza, Kesimpta, Rybrevant, Tivdak, and Epkinly for various oncologic indications. With a strong pipeline of candidates, Genmab is working on advancing sustainable healthcare solutions.
Key Insights
Key Insights
Covered by 3 ESG rating providers
Strong coverage
No public Net Zero target found
68% of Fortune 500 have targets
Consider science-based targets
72% of G7 companies have SBTi targets
Sustainability Commitments & Climate Targets
Genmab A/S ESG Rating Coverage - Sustainalytics & LSEG
Analyzed by both major ESG rating providers - verified
| Provider | Coverage | Details |
|---|---|---|
Morningstar Sustainalytics ESG Risk Ratings | Covered | |
LSEG (Refinitiv) ESG Scores & Data | Covered |
Coverage verified from 2 of 2 active providers.
ESG Rating Provider Coverage
MSCI ESG Ratings
Measures company exposure to industry-specific ESG risks and management of those risks relative to peers.
MSCI identifies the ESG risks most relevant to each industry, then scores companies on how well they manage those risks compared to peers. Ratings range from AAA (leader) to CCC (laggard) and are reviewed annually.
View on MSCIMorningstar Sustainalytics ESG Risk Ratings
Assesses the degree to which a company's economic value is at risk driven by ESG factors.
Sustainalytics measures unmanaged ESG risk — the gap between a company's total exposure to material ESG issues and how much of that exposure its management practices address. Lower scores indicate less unmanaged risk.
View on SustainalyticsLSEG (Refinitiv) ESG Scores
Evaluates company ESG performance based on publicly available, verifiable data across 630+ metrics.
LSEG scores companies across 630+ ESG data points drawn entirely from public disclosures — annual reports, sustainability filings, and regulatory submissions. Scores are weighted by industry materiality and benchmarked against sector peers.
View on LSEGCDPEnvironmental disclosure system for companies, cities, and statesCoverage status indicates whether publicly available ESG data from each provider has been identified for Genmab A/S. For official ratings and scores, visit provider websites directly.
ESG Solutions for HealthCare
ReadySet
ReadySet offers innovative tools and strategies to enhance social governance, ensuring ethical and sustainable business practices.
Peoplism
Peoplism offers science-backed HR consulting and training to improve hiring, performance, engagement, DEI, and leadership skills.
She+ Geeks Out
She+ Geeks Out helps organizations evolve with strategic consulting, coaching, and learning, centering people at the core.
Syndio
Syndio empowers enterprises with AI-powered compensation workflows, ensuring fair pay decisions and compliance with EUPTD standards.
Eskalera
Eskalera provides advanced tools for enhancing workplace diversity, equity, and inclusion, driving positive social impact.
Inclusion Score
Inclusion Score offers innovative tools to enhance diversity, equity, and inclusion in organizations worldwide.